These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 33236497)

  • 1. Prevalence and prognostic impact of hsCRP elevation are age-dependent in women but not in men undergoing percutaneous coronary intervention.
    Blum M; Cao D; Chandiramani R; Goel R; Roumeliotis A; Sartori S; Beyhoff N; Kelle S; Kovacic JC; Krishnan P; Sweeny J; Barman N; Baber U; Dangas GD; Kini A; Sharma SK; Mehran R
    Catheter Cardiovasc Interv; 2021 Jun; 97(7):E936-E944. PubMed ID: 33236497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Impact of High-Sensitivity C-Reactive Protein in Patients Undergoing Percutaneous Coronary Intervention According to BMI.
    Beyhoff N; Cao D; Mehran R; Dangas G; Baber U; Sartori S; Blum M; Roumeliotis A; Chandiramani R; Goel R; Zhang Z; Kovacic J; Krishnan P; Barman N; Kapur V; Sweeny J; Sharma SK; Kini A
    JACC Cardiovasc Interv; 2020 Dec; 13(24):2882-2892. PubMed ID: 33357526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of preprocedural high-sensitivity C-reactive protein on contrast-induced nephropathy in patients undergoing primary percutaneous coronary intervention.
    Jian-Wei Z; Yu-Jie Z; Shu-Jun C; Qing Y; Shi-Wei Y; Bin N
    Angiology; 2014 May; 65(5):402-7. PubMed ID: 23539615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Elevated C-Reactive Protein on Outcomes After Complex Percutaneous Coronary Intervention for Angina Pectoris.
    Camaj A; Giustino G; Kocovic N; Cao D; Claessen BE; Sartori S; Zhang Z; Qiu H; Nicolas J; Hinohara T; Baber U; Power DA; Barman N; Sweeny J; Dangas G; Kini A; Sharma SK; Mehran R
    Am J Cardiol; 2022 Apr; 168():47-54. PubMed ID: 35058052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Postprocedural High-Sensitivity C-Reactive Protein on Lipoprotein(a)-Associated Cardiovascular Risk with ST-Segment Elevation Myocardial Infarction With Percutaneous Coronary Intervention.
    Wang Y; Zhao X; Zhou P; Liu C; Chen R; Sheng Z; Li J; Zhou J; Song L; Zhao H; Yan H
    Am J Cardiol; 2021 Jul; 150():8-14. PubMed ID: 34006374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Value of Baseline Inflammation in Diabetic and Nondiabetic Patients Undergoing Percutaneous Coronary Intervention.
    Pivato CA; Jones D; Cao D; Sartori S; Chiarito M; Nicolas J; Zhang Z; Beerkens F; Nardin M; Qiu H; Razuk V; Feldman D; Kumaraguru V; Stefanini GG; Sweeny J; Baber U; Dangas G; Sharma SK; Kini A; Mehran R
    Can J Cardiol; 2022 Jun; 38(6):792-800. PubMed ID: 35151783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The predictive value of plasma cystatin C for non-ST-elevation acute coronary syndrome treated with percutaneous coronary intervention].
    Yan S; Zhang X; Tian X; Li J; Zhuang L; Zhang X; Jiang Y
    Zhonghua Yi Xue Za Zhi; 2014 Jan; 94(1):10-3. PubMed ID: 24721298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein(a), high-sensitivity C-reactive protein, and cardiovascular risk in patients undergoing percutaneous coronary intervention.
    Yuan D; Wang P; Jia S; Zhang C; Zhu P; Jiang L; Liu R; Xu J; Tang X; Song Y; Yao Y; Xu N; Zhang Y; Zhao X; Yang Y; Xu B; Gao L; Gao Z; Gao R; Yuan J
    Atherosclerosis; 2022 Dec; 363():109-116. PubMed ID: 36357218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal Dysfunction and hsCRP Predict Long-term Outcomes of Percutaneous Coronary Intervention in Acute Myocardial Infarction.
    Wang CH; Zhang SY; Fang Q; Shen ZJ; Fan ZJ; Jin XF; Zeng Y; Liu ZY; Xie HZ
    Am J Med Sci; 2015 May; 349(5):413-20. PubMed ID: 25782335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Residual Inflammatory Risk in Patients With Low LDL Cholesterol Levels Undergoing Percutaneous Coronary Intervention.
    Guedeney P; Claessen BE; Kalkman DN; Aquino M; Sorrentino S; Giustino G; Farhan S; Vogel B; Sartori S; Montalescot G; Sweeny J; Kovacic JC; Krishnan P; Barman N; Dangas G; Kini A; Baber U; Sharma S; Mehran R
    J Am Coll Cardiol; 2019 May; 73(19):2401-2409. PubMed ID: 31097159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Residual inflammatory risk and the impact on clinical outcomes in patients after percutaneous coronary interventions.
    Kalkman DN; Aquino M; Claessen BE; Baber U; Guedeney P; Sorrentino S; Vogel B; de Winter RJ; Sweeny J; Kovacic JC; Shah S; Vijay P; Barman N; Kini A; Sharma S; Dangas GD; Mehran R
    Eur Heart J; 2018 Dec; 39(46):4101-4108. PubMed ID: 30358832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined and independent impact of coronary artery calcification and inflammation on risk for adverse cardiovascular events after percutaneous coronary intervention: Results from a large single-center registry.
    Aoi S; Baber U; Kovacic JC; Mehran R; Aquino M; Dangas G; Sweeny J; Vijay P; Shah S; Barman N; Moreno P; Kini AS; Sharma SK
    Catheter Cardiovasc Interv; 2020 Sep; 96(3):E278-E286. PubMed ID: 32087000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of sex difference in clinical presentation (stable coronary artery disease vs unstable angina pectoris or non-ST-elevation myocardial infarction vs ST-elevation myocardial infarction) on 2-year outcomes in patients undergoing percutaneous coronary intervention.
    Tang XF; Song Y; Xu JJ; Ma YL; Zhang JH; Yao Y; He C; Wang HH; Jiang P; Jiang L; Liu R; Gao Z; Zhao XY; Qiao SB; Xu B; Yang YJ; Gao RL; Yuan JQ
    J Interv Cardiol; 2018 Feb; 31(1):5-14. PubMed ID: 29023996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical impact of sex differences on ischemic postconditioning during primary percutaneous coronary intervention: a POST (the effects of postconditioning on myocardial reperfusion in patients with ST-segment elevation myocardial infarction) substudy.
    Shin ES; Chung JH; Hahn JY; Song YB; Kim EK; Yu CW; Bae JW; Chung WY; Choi SH; Choi JH; Bae JH; An KJ; Park JS; Oh JH; Kim SW; Hwang JY; Ryu JK; Garg S; Lim DS; Gwon HC; Park HS
    Heart Vessels; 2019 Jun; 34(6):898-905. PubMed ID: 30519807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth differentiation factor-15 levels and the risk of contrast induced nephropathy in patients with acute myocardial infarction undergoing percutaneous coronary intervention: A retrospective observation study.
    Sun L; Zhou X; Jiang J; Zang X; Chen X; Li H; Cao H; Wang Q
    PLoS One; 2018; 13(5):e0197609. PubMed ID: 29791474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential Impact of Cigarette Smoking on Prognosis in Women and Men Undergoing Percutaneous Coronary Intervention.
    Yang LX; Wang ZJ; Shi DM; Chai M; Zhang L; Cheng WJ; Zhou YJ
    Angiology; 2020 Mar; 71(3):281-287. PubMed ID: 31777276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High high-sensitivity C-reactive protein/BMI ratio predicts future adverse outcomes in patients with acute coronary syndrome.
    Jia L; Yuan JQ; Zhu L; Zhang Y
    Coron Artery Dis; 2019 Sep; 30(6):448-454. PubMed ID: 31386638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Staged complete revascularization or culprit-only percutaneous coronary intervention for multivessel coronary artery disease in patients with ST-segment elevation myocardial infarction and diabetes.
    Cui K; Lyu S; Liu H; Song X; Yuan F; Xu F; Zhang M; Wang W; Zhang M; Zhang D; Tian J
    Cardiovasc Diabetol; 2019 Sep; 18(1):119. PubMed ID: 31530274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-sensitivity C-reactive protein predicts 10-year cardiovascular outcome after percutaneous coronary intervention.
    Oemrawsingh RM; Cheng JM; Akkerhuis KM; Kardys I; Degertekin M; van Geuns RJ; Daemen J; Boersma E; Serruys PW; van Domburg RT
    EuroIntervention; 2016 Jun; 12(3):345-51. PubMed ID: 26158553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex-related differences in outcomes among men and women under 55 years of age with acute coronary syndrome undergoing percutaneous coronary intervention: Results from the PROMETHEUS study.
    Chandrasekhar J; Baber U; Sartori S; Faggioni M; Aquino M; Kini A; Weintraub W; Rao S; Kapadia S; Weiss S; Strauss C; Toma C; Muhlestein B; DeFranco A; Effron M; Keller S; Baker B; Pocock S; Henry T; Mehran R
    Catheter Cardiovasc Interv; 2017 Mar; 89(4):629-637. PubMed ID: 27152497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.